期刊文献+

脑胶质瘤患者预后影响因素分析 被引量:16

An Analysis on Prognostic Factors in Patients with Glioma
原文传递
导出
摘要 [目的]探讨脑胶质瘤患者预后影响因素,以提高胶质瘤患者术后生存率。[方法]外科手术后经病理确诊为脑胶质瘤的患者158例,查找病历和电话随访收集其资料,生存分析单因素分析使用Kaplan-Meier法计算生存率,并采用Log-rank检验;多因素分析采用Cox分析。[结果]单因素分析表明影响预后的因素有:年龄、肿瘤级别、KPS评分、术后放疗和化疗。多因素分析显示年龄、肿瘤级别、KPS评分、术后放疗和化疗是影响预后的独立因素。[结论]年龄小、级别低、KPS评分高的患者术后预后较好,术后辅助放疗或者化疗有助于改善预后。 [Purpose] To investigate the prognostic factors and to improve the survival in patients with glioma after operation. [Methods] A total of 158 patients with gliomas confirmed by pathology were collected. The clinical data was collected by scanning medical records and telephone followup.Kaplan-Meier method and Log-rank test was used in univariate analysis whereas Cox analysis was used in multivariate analysis. [Results] Univariate analysis and multivariate analysis both showed that the prognostic factors were age,pathology grade,KPS score,postoperative radiotherapy and chemotherapy. [Conclusions] Better prognosis of glioma patients are depending on lower age and pathology grade,higher KPS score,and postoperative radiotherapy and chemotherapy.
出处 《中国肿瘤》 CAS 2014年第12期1019-1023,共5页 China Cancer
关键词 胶质瘤 预后 生存率 glioma prognosis survival
  • 相关文献

参考文献8

二级参考文献86

共引文献123

同被引文献163

  • 1钟佳伟,牟福玲,孙鹏飞.胶质瘤放化疗敏感性的研究进展[J].中国肿瘤,2020,0(4):299-303. 被引量:11
  • 2张华楸,舒凯,叶飞,郭东升,牛洪泉,雷霆,李龄.脑胶质瘤病的诊断和治疗[J].中华神经医学杂志,2005,4(6):582-584. 被引量:10
  • 3全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50. 被引量:63
  • 4国家癌症中心.卫生部疾病预防控制局.中国癌症发病与死亡2003-2007[M].北京:军事医学科学出版社,2012.8,15-18. 被引量:6
  • 5赫捷,赵平,陈万青.2012年中国肿瘤登记年报[M].北京:军事医学科学出版社,2012.56-59. 被引量:35
  • 6周绍兵,刘阳晨,高飞,叶宏勋,赵莺,尹小祥.恶性脑胶质瘤术后替莫唑胺化疗联合适形放疗的疗效观察[J].现代肿瘤医学,2008,16(1):34-35. 被引量:9
  • 7WHO.GLOBOCAN 2012:estimated cancer incidence, mortality and prevalence worldwide in 2012[EB/OL]. http: //globocan.iarc.fr/Pages/fact_sheets_cancer.aspx, 2015 - 02-24. 被引量:1
  • 8Curado MPEB,Slain HR,Storm H,et al. Cancer Inci- dence in Five Continents,Vol. IX[M]. Lyon :IARC Scien- tific Publication, 2008. 1-837. 被引量:1
  • 9Felay L, Rurkhard C,Whelan S,et al. Check and Con- version Programs for Cancer Registries. IARC Technical Report No.42[M]. Lyon : IARC, 2005. 被引量:1
  • 10Bray F, Parkin DM. Evaluation of data quality in the can- cer registry :principles and methods. Part I :comparabili- ty,validity and timeliness[J]. Eur J Cancer, 2009,45(5): 747-755. 被引量:1

引证文献16

二级引证文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部